News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Paolo Tarantino: Abemaciclib Improves Survival in High-Risk HR Positive HER2 Negative Breast Cancer
Paolo Tarantino/X
Aug 28, 2025, 16:14

Paolo Tarantino: Abemaciclib Improves Survival in High-Risk HR Positive HER2 Negative Breast Cancer

Paolo Tarantino, 2025 Yvonne’s “Top Voice” Award Winner, Associate Editor for Breast Cancer at ESMO Open, shared a post on X:

”Press release from monarchE: At the 7-year analysis, adjuvant abemaciclib significantly improved overall survival. Something we rarely see in the early-stage setting and which further reinforces the role of adjuvant CDK4/6 inhibitors for high-risk HR+/HER2- breast cancer.”

Paolo Tarantino

More posts featuring Paolo Tarantino.

Abemaciclib Breast Cancer cancer ESMO Open OncoDaily Oncology Paolo Tarantino
Special Coverage
Trial Updates
Aug 28, 2025, 16:14
Paolo Tarantino: Abemaciclib Improves Survival in High-Risk HR Positive HER2 Negative Breast Cancer
Insight
Aug 28, 2025, 16:12
Redefining Precision Medicine Beyond Oncology with AI and Real-World Data - Amgen
Voices
Aug 28, 2025, 16:10
Special Message from JPORP Advisory Board Member Clarissa Schilstra - IPOS
Radiotherapy
Aug 28, 2025, 16:02
Jeff White: Shining a Light on World Radiation Therapy Awareness Day
Insight
Aug 28, 2025, 15:59
Primoz Petric: INTERLACE - Not a New Standard for Cervical Cancer Chemoradiation
Trial Updates
Aug 28, 2025, 15:56
Raul Cordoba: COVID-19 and Bispecific Antibodies in Blood Cancer
Trial Updates
Aug 28, 2025, 15:55
David Heredia: LEOPARD Study Highlights Early NSCLC Recurrence
Trial Updates
Aug 28, 2025, 15:55
ANKTIVA NK Cell Therapy Shows 100 Percent Disease Control in Recurrent Glioblastoma - ImmunityBio
Insight
Aug 28, 2025, 15:54
Bishal Gyawali: Inferior Control Arms in LMIC Oncology Trials in a New BMJ Oncology Editorial
Voices
Aug 28, 2025, 15:53
Talha Badar: TP53-Mutated MPN in British Journal of Haematology
Career Updates
Aug 28, 2025, 15:52
Hassan Abushukair: Celebrating My Term as Co-Chair of the AACR Global Scholars Alumni Committee
Voices
Aug 28, 2025, 15:48
ESO and OECI Invite Clinicians and Researchers to Contribute to the 10th CCI4EU Training Cours